• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌肽 PR39 递送 Stat3siRNA 抑制乳腺癌细胞的侵袭和迁移。

Suppression of tumor invasion and migration in breast cancer cells following delivery of siRNA against Stat3 with the antimicrobial peptide PR39.

机构信息

Department of Laboratory Medicine, Key Laboratory of Diagnostic Medicine, Ministry of Education, Chongqing Medical University, Chongqing 400016, PR China.

出版信息

Oncol Rep. 2012 Oct;28(4):1362-8. doi: 10.3892/or.2012.1911. Epub 2012 Jul 13.

DOI:10.3892/or.2012.1911
PMID:22797782
Abstract

PR39, a porcine cathelicidin rich in the amino acids proline and arginine can interact with the negatively charged component of the cell surface, and rapidly penetrate cell membranes. Therefore, we hypothesized that PR39, as a membrane penetrating peptide (MPP), could be exploited as a novel carrier to deliver siRNA into the cell cytoplasm in order to knockdown target gene expression. Firstly, a complex formation of PR39 with siRNA and its cellular colocalization were investigated in our studies. Further, we optimized the ratio of the PR39/siRNA complex, cell/complex incubation period and the concentration of siRNA. The results suggest that PR39 could form a complex with siRNA, and mediate translocation of the siRNA into 4T1 cells. The optimal ratio of siRNA with PR39 was 1:90 which was found to have a maximum Stat3 gene silencing effect after 48 h treatment. Moreover, 4T1 cell proliferation, cell cycle, invasion and migration were investigated. The results suggested that Stat3 knockdown could not result in 4T1 cell proliferation inhibition and cell cycle arrest, while invasion and migration of 4T1 cells were strongly inhibited. Notably, the data also showed that in addition to inhibition of carcinogenesis, single PR39 may play a role in cell invasion and migration. PR39 and Stat3 siRNA displayed synergistic biological effects in inhibiting cell invasion and migration of 4T1 cells, which was more prominent compared with the popular Lipofectamine delivery system.

摘要

富含脯氨酸和精氨酸的猪 cathelicidin(PR39)可以与细胞表面的带负电荷的成分相互作用,并迅速穿透细胞膜。因此,我们假设 PR39 可以作为一种新型载体,利用其穿透细胞膜的肽(MPP)特性将 siRNA 递送至细胞质中,以达到敲低靶基因表达的目的。首先,我们研究了 PR39 与 siRNA 的复合物形成及其在细胞内的共定位。进一步,我们优化了 PR39/siRNA 复合物的比例、细胞/复合物孵育时间和 siRNA 的浓度。结果表明,PR39 可以与 siRNA 形成复合物,并介导 siRNA 转染至 4T1 细胞。我们发现,PR39 与 siRNA 的最佳比例为 1:90,在 48 小时处理后可达到最大的 Stat3 基因沉默效果。此外,我们还研究了 4T1 细胞的增殖、细胞周期、侵袭和迁移。结果表明,Stat3 基因沉默不会导致 4T1 细胞增殖抑制和细胞周期停滞,但可强烈抑制 4T1 细胞的侵袭和迁移。值得注意的是,这些数据还表明,除了抑制肿瘤发生外,单一 PR39 可能在细胞侵袭和迁移中发挥作用。PR39 和 Stat3 siRNA 在抑制 4T1 细胞的侵袭和迁移方面表现出协同的生物学效应,与流行的 Lipofectamine 递送系统相比,这种协同效应更加显著。

相似文献

1
Suppression of tumor invasion and migration in breast cancer cells following delivery of siRNA against Stat3 with the antimicrobial peptide PR39.抗菌肽 PR39 递送 Stat3siRNA 抑制乳腺癌细胞的侵袭和迁移。
Oncol Rep. 2012 Oct;28(4):1362-8. doi: 10.3892/or.2012.1911. Epub 2012 Jul 13.
2
[Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].[靶向转录信号转导子与激活子3的小干扰RNA对乳腺癌细胞的体内外生长抑制作用]
Zhonghua Zhong Liu Za Zhi. 2010 Nov;32(11):819-24.
3
Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.信号转导子和转录激活子 3 siRNA 对异种移植小鼠人乳腺癌的治疗作用。
Chin Med J (Engl). 2011 Jun;124(12):1854-61.
4
PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2.PR39抑制缺氧内皮细胞凋亡:凋亡抑制蛋白-2的作用
Circulation. 2004 Apr 6;109(13):1660-7. doi: 10.1161/01.CIR.0000124067.35915.E0. Epub 2004 Mar 15.
5
The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.脂质取代型聚亚乙基亚胺介导的 STAT3 siRNA 递送诱导 B16 黑色素瘤细胞凋亡。
Biomaterials. 2010 Feb;31(6):1420-8. doi: 10.1016/j.biomaterials.2009.11.003. Epub 2009 Nov 13.
6
Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.载有针对 STAT3 的 siRNA 的纳米粒子的药物传递和抗癌潜力的评估:在肺癌中的体内外研究。
Toxicol Lett. 2014 Mar 21;225(3):454-66. doi: 10.1016/j.toxlet.2014.01.009. Epub 2014 Jan 17.
7
STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.靶向 STAT3 的 RNA 干扰抑制体内外胰腺癌血管生成。
Int J Oncol. 2011 Jun;38(6):1637-44. doi: 10.3892/ijo.2011.1000. Epub 2011 Apr 8.
8
[Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].聚酰胺胺树枝状大分子介导的短发夹RNA沉默STAT3基因对前列腺癌生长的抑制作用
Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):575-9.
9
Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.通过小干扰RNA(siRNA)与脂质取代聚乙烯亚胺的多聚体有效下调信号转导与转录激活因子3(STAT3),使乳腺肿瘤细胞对传统化疗敏感。
J Biomed Mater Res A. 2014 Sep;102(9):3216-28. doi: 10.1002/jbm.a.34992. Epub 2013 Oct 25.
10
Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.通过RNA干扰降低STAT3表达可抑制免疫活性小鼠乳腺肿瘤的诱发。
Cancer Res. 2005 Apr 1;65(7):2532-6. doi: 10.1158/0008-5472.CAN-04-2425.

引用本文的文献

1
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines.小核酸疗法全景:作为下一代药物从实验室走向临床
Signal Transduct Target Ther. 2025 Mar 10;10(1):73. doi: 10.1038/s41392-024-02112-8.
2
Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer.siRNA 的治疗递送在乳腺癌和三阴性乳腺癌治疗中的应用。
Ther Deliv. 2024;15(11):871-891. doi: 10.1080/20415990.2024.2400044. Epub 2024 Sep 25.
3
Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nano Agents.
抗菌肽及其纳米制剂的抗癌机制与潜在抗癌应用
Int J Nanomedicine. 2024 Feb 1;19:1017-1039. doi: 10.2147/IJN.S445333. eCollection 2024.
4
Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer-Drug Carriers Matter.用于癌症治疗中靶向STAT3的基于寡核苷酸的疗法——药物载体很重要。
Cancers (Basel). 2023 Nov 29;15(23):5647. doi: 10.3390/cancers15235647.
5
Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer's disease-like neuroinflammation triggered by periodontal disease.尼生素是一种益生菌细菌素,可减轻牙周病引发的大脑微生物组失调和类似阿尔茨海默病的神经炎症。
J Neuroinflammation. 2023 Oct 6;20(1):228. doi: 10.1186/s12974-023-02915-6.
6
Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture.尼生素 ZP,一种抗菌肽,在 2D 和 3D 细胞培养中诱导细胞死亡并抑制非小细胞肺癌(NSCLC)进展。
Pharm Res. 2022 Nov;39(11):2859-2870. doi: 10.1007/s11095-022-03220-2. Epub 2022 Mar 4.
7
Bioactive cationic peptides as potential agents for breast cancer treatment.生物活性阳离子肽作为治疗乳腺癌的潜在药物。
Biosci Rep. 2021 Dec 22;41(12). doi: 10.1042/BSR20211218C.
8
Antibacterial activity of a dual peptide targeting the sliding clamp and the ribosome.一种靶向滑动夹和核糖体的双肽的抗菌活性
RSC Chem Biol. 2020 Jul 16;1(3):137-147. doi: 10.1039/d0cb00060d. eCollection 2020 Aug 1.
9
Antimicrobial peptide 17BIPHE2 inhibits the proliferation of lung cancer cells and by regulating the ERK signaling pathway.抗菌肽17BIPHE2通过调节ERK信号通路抑制肺癌细胞的增殖。
Oncol Lett. 2021 Jul;22(1):501. doi: 10.3892/ol.2021.12762. Epub 2021 Apr 28.
10
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer.基于 PLL[30]-PEG[5K] 的 Chol-DsiRNA 超分子聚合物用于乳腺癌 RNAi 治疗的初步临床前研究。
Nanomedicine. 2021 Apr;33:102363. doi: 10.1016/j.nano.2021.102363. Epub 2021 Feb 3.